Hier beginnt der Kopfbereich - Meta-Navigation und Logos

Kein Link zur Sprachversion EN EN

Hier beginnt die Unternavigation für den Bereich

Ihr Ausdruck wurde in der folgenden Navigationsebene erstellt:

Hier beginnt der Inhaltsbereich
Herzlich willkommen im Portal für unsere Kollegen und Partner in der Medizin!
Visual Content 1
Visual Content 2



J. J. Aponte, D. Schellenberg, A. Egan, A. Breckenridge, I. Carneiro, J. Critchley, I. Danquah, A. Dodoo, R. Kobbe, B. Lell, J. May, Z. Premji, S. Sanz, E. Sevene, R. Soulaymani-Becheikh, P. Winstanley, S. Adjei, S. Anemana, D. Chandramohan, S. Issifou, F. Mockenhaupt, S. Owusu-Agyei, B. Greenwood, M. P. Grobusch, P. G. Kremsner, E. Macete, H. Mshinda, R. D. Newman, L. Slutsker, M. Tanner, P. Alonso, and C. Menendez: Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.Lancet 374: 1533-1542 (2009)


N. Bahamontes-Rosa, K. Bucher, J. Held, A. Robin, W. H. Hoffmann, S. L. Flitsch, P. G. Kremsner, and J. F. Kun: In vivo anti-malarial effect of the beta-amino alcohol 1t on Plasmodium berghei.Parasitology Research 104: 1459-1464 (2009)


N. K. Bayoumi, K. H. Bakhet, A. A. Mohmmed, A. M. Eltom, M. I. Elbashir, E. Mavoungou, and I. Adam: Cytokine profiles in peripheral, placental and cord blood in an area of unstable malaria transmission in eastern Sudan.Journal of Tropical Pediatrics 55: 233-237 (2009)


A. B. Boldt, I. J. Messias-Reason, B. Lell, S. Issifou, M. L. Pedroso, P. G. Kremsner, and J. F. Kun: Haplotype specific-sequencing reveals MBL2 association with asymptomatic Plasmodium falciparum infection.Malaria Journal 8: 97 (2009)


Angelica B. W. Boldt, Lodércio Culpi, Luiza T. Tsuneto, Iliada R. Souza, Jürgen F. J. Kun, and Maria Luiza Petzl-Erler: Analysis of the CCR5 gene coding region diversity in five South American populations reveals two new non-synonymous alleles in Amerindians and high CCR5*D32 frequency in Euro-Brazilians.Genetics and Molecular Biology 32: 12-19 (2009)


M. K. Bouyou-Akotet, D. P. Mawili-Mboumba, E. Kendjo, M. Mabika-Mamfoumbi, E. B. Ngoungou, A. Dzeing-Ella, M. Pemba-Mihindou, E. Ibinga, E. Efame-Eya, T. Planche, P. G. Kremsner, and M. Kombila: Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008.Malaria Journal 8: 300 (2009)


Meskure Capan, Sebastian Keltner, Florian Thalhammer, Stefan Winkler, Walter Jager, Markus Zeitlinger, and Michael Ramharter: Intra-Cystic Drug Concentration of Albendazole Sulphoxide in Patients with Echinococcus granulosus Cysts.American Journal of Tropical Medicine and Hygiene 81: 712-713 (2009)


I. Danquah, E. Dietz, P. Zanger, K. Reither, P. Ziniel, U. Bienzle, and F. P. Mockenhaupt: Reduced efficacy of intermittent preventive treatment of malaria in malnourished children.Antimicrobial Agents and Chemotherapy 53: 1753-1759 (2009)


A. Dietmann, R. Helbok, P. Lackner, M. Fischer, M. Reindl, B. Lell, S. Issifou, P. G. Kremsner, and E. Schmutzhard: Endoglin in African children with Plasmodium falciparum malaria: a novel player in severe malaria pathogenesis?Journal of Infectious Diseases 200: 1842-1848 (2009)


M. Esen, P. G. Kremsner, R. Schleucher, M. Gassler, E. B. Imoukhuede, N. Imbault, O. Leroy, S. Jepsen, B. W. Knudsen, M. Schumm, J. Knobloch, M. Theisen, and B. Mordmuller: Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate.Vaccine 27: 6862-6868 (2009)


M. Esen, B. Mordmuller, and P. G. Kremsner: Immunological tests to diagnose active tuberculosis.Journal of Internal Medicine 265: 159-162 (2009)


I. Faik, E. G. de Carvalho, and J. F. Kun: Parasite-host interaction in malaria: genetic clues and copy number variation.Genome Med 1: 82 (2009)


M. P. Grobusch, J. J. Gabor, J. J. Aponte, N. G. Schwarz, M. Poetschke, J. Doernemann, K. Schuster, K. B. Koester, K. Profanter, L. B. Borchert, F. Kurth, P. Pongratz, S. Issifou, B. Lell, and P. G. Kremsner: No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon.Journal of Infectious Diseases 200: 1658-1661 (2009)


M. Gysels, C. Pell, D. P. Mathanga, P. Adongo, F. Odhiambo, R. Gosling, P. Akweongo, R. Mwangi, G. Okello, P. Mangesho, L. Slutsker, P. G. Kremsner, M. P. Grobusch, M. J. Hamel, R. D. Newman, and R. Pool: Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings.Malaria Journal 8: 191-(2009)


D. M. Hamm, A. Agossou, R. G. Gantin, L. Kocherscheidt, M. Banla, K. Dietz, and P. T. Soboslay: Coinfections with Schistosoma haematobium, Necator americanus, and Entamoeba histolytica/Entamoeba dispar in children: chemokine and cytokine responses and changes after antiparasite treatment.Journal of Infectious Diseases 199: 1583-1591 (2009)


T. Hanscheid, R. Frita, M. Langin, P. G. Kremsner, and M. P. Grobusch: Is flow cytometry better in counting malaria pigment-containing leukocytes compared to microscopy?Malaria Journal 8: 255-(2009)


T. Hanscheid, M. Langin, V. Codices, A. J. Luty, A. A. Adegnika, P. G. Kremsner, and M. P. Grobusch: Automated detection of haemozoin-containing monocytes for the diagnosis of malaria in microscopically negative cases during pregnancy.Acta Tropica 109: 245-246 (2009)


R. Helbok, E. Kendjo, S. Issifou, P. Lackner, C. R. Newton, M. Kombila, T. Agbenyega, K. Bojang, K. Dietz, E. Schmutzhard, and P. G. Kremsner: The Lambarene Organ Dysfunction Score (LODS) is a simple clinical predictor of fatal malaria in African children.Journal of Infectious Diseases 200: 1834-1841 (2009)


Y. Kalmbach, A. B. Boldt, B. Mordmuller, M. Kombila, M. P. Grobusch, P. G. Kremsner, and J. F. Kun: Reduced CD3/TCR complex expression leads to immunosuppression during Plasmodium falciparum malaria.Parasitology Research 104: 575-582 (2009)


R. Kerb, R. Fux, K. Morike, P. G. Kremsner, J. P. Gil, C. H. Gleiter, and M. Schwab: Pharmacogenetics of antimalarial drugs: effect on metabolism and transport.Lancet Infectious Diseases 9: 760-774 (2009)


P. G. Kremsner, C. Valim, M. A. Missinou, C. Olola, S. Krishna, S. Issifou, M. Kombila, L. Bwanaisa, S. Mithwani, C. R. Newton, T. Agbenyega, M. Pinder, K. Bojang, D. Wypij, and T. Taylor: Prognostic value of circulating pigmented cells in African children with malaria.Journal of Infectious Diseases 199: 142-150 (2009)


J. F. Kun and E. G. de Carvalho: Novel therapeutic targets in Plasmodium falciparum: aquaglyceroporins.Expert Opinion on Therapeutic Targets 13: 385-394 (2009)


F. Kurth, P. Pongratz, S. Belard, B. Mordmuller, P. G. Kremsner, and M. Ramharter: In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.Malaria Journal 8: 79 (2009)


P. A. Lang, R. S. Kasinathan, V. B. Brand, C. Duranton, C. Lang, S. Koka, E. Shumilina, D. S. Kempe, V. Tanneur, A. Akel, K. S. Lang, M. Foller, J. F. Kun, P. G. Kremsner, S. Wesselborg, S. Laufer, C. S. Clemen, C. Herr, A. A. Noegel, T. Wieder, E. Gulbins, F. Lang, and S. M. Huber: Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency.Cellular Physiology and Biochemistry 24: 415-428 (2009)


B. Lell, S. Agnandji, Glasenapp von, I, S. Haertle, S. Oyakhiromen, S. Issifou, J. Vekemans, A. Leach, M. Lievens, M. C. Dubois, M. A. Demoitie, T. Carter, T. Villafana, W. R. Ballou, J. Cohen, and P. G. Kremsner: A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon.PLoS One 4: e7611 (2009)


X. Li, H. Chen, N. Bahamontes-Rosa, J. F. Kun, B. Traore, P. D. Crompton, and A. H. Chishti: Plasmodium falciparum signal peptide peptidase is a promising drug target against blood stage malaria.Biochemical Biophysical Research Communications 380: 454-459 (2009)


D. C. Macallan, D. A. Abaye, S. Dottin, M. Onanga, M. Kombila, A. Dzeing-Ella, P. G. Kremsner, S. Krishna, and T. Planche: Blood volume and red cell mass in children with moderate and severe malaria measured by chromium-53 dilution and gas chromatography/mass spectrometric analysis.Rapid Communications in Mass Spectrometry 23: 2467-2475 (2009)


P. I. Mayengue, A. J. Luty, C. Rogier, M. Baragatti, P. G. Kremsner, and F. Ntoumi: The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens.Microbes and Infection 11: 108-114 (2009)


I. Messias-Reason, P. G. Kremsner, and J. F. Kun: Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy.Journal of Infectious Diseases 199: 801-804 (2009)


I. J. Messias-Reason, M. D. Schafranski, P. G. Kremsner, and J. F. Kun: Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease.Clinical and Experimantal Immunology 157: 395-399 (2009)


W. G. Metzger, A. M. Giron, S. Vivas-Martinez, J. Gonzalez, A. J. Charrasco, B. G. Mordmuller, and M. Magris: A rapid malaria appraisal in the Venezuelan Amazon.Malaria Journal 8: 291 (2009)


L. Mewono, S. T. Agnandji, D. W. Matondo Maya, A. M. Mouima, B. A. Iroungou, S. Issifou, and P. G. Kremsner: Malaria antigen-mediated enhancement of interleukin-21 responses of peripheral blood mononuclear cells in African adults.Experimantal Parasitology 122: 37-40 (2009)


R. J. Pearce, H. Pota, M. S. Evehe, el Ba, G. Mombo-Ngoma, A. L. Malisa, R. Ord, W. Inojosa, A. Matondo, D. A. Diallo, W. Mbacham, den Broek van, IV, T. D. Swarthout, A. Getachew, S. Dejene, M. P. Grobusch, F. Njie, S. Dunyo, M. Kweku, S. Owusu-Agyei, D. Chandramohan, M. Bonnet, J. P. Guthmann, S. Clarke, K. I. Barnes, E. Streat, S. T. Katokele, P. Uusiku, C. O. Agboghoroma, O. Y. Elegba, B. Cisse, I. E. Elbasit, H. A. Giha, S. P. Kachur, C. Lynch, J. B. Rwakimari, P. Chanda, M. Hawela, B. Sharp, I. Naidoo, and C. Roper: Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.PLoS Med 6: e1000055 (2009)


A. M. Schoepfer, B. Flogerzi, B. Seibold-Schmid, T. Schaffer, J. F. Kun, V. Pittet, S. Mueller, and F. Seibold: Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).The American Journal of Gastroenterology 104: 2508-2516 (2009)


N. G. Schwarz, M. Gysels, C. Pell, J. Gabor, M. Schlie, S. Issifou, B. Lell, P. G. Kremsner, M. P. Grobusch, and R. Pool: Reasons for non-adherence to vaccination at mother and child care clinics (MCCs) in Lambarene, Gabon.Vaccine 27: 5371-5375 (2009)


T. P. Velavan, H. Schulenburg, and N. K. Michiels: Detection of multiple infections by Monocystis strains in a single earthworm host using ribosomal internal transcribed spacer sequence variation.Parasitology 1-7 (2009)


T. P. Velavan, S. Weller, H. Schulenburg, and N. K. Michiels: High genetic diversity and heterogeneous parasite load in the earthworm Lumbricus terrestris on a German meadow.Soil Biology & Biochemistry 41: 1591-1595 (2009)


M. Yazdanbakhsh and P. G. Kremsner: Influenza in Africa.PLoS Med 6: e1000182 (2009)


P. Zanger, J. Holzer, R. Schleucher, H. Steffen, B. Schittek, and S. Gabrysch: Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin.Journal of Infectious Diseases 200: 1907-1915 (2009)





Hier beginnt die Marginalspalte Suche und verschieden Module

Hier beginnt die Fusszeile - Impressum und Datenschutz
Cookie Einstellungen
Bitte treffen Sie eine Auswahl um fortzufahren.
Weitere Informationen zu den Auswirkungen Ihrer Auswahl finden Sie unter HILFE.
Um fortfahren zu können, müssen Sie eine Cookie-Auswahl treffen.

Cookies zulassen:
Wir setzen Analysetools (Google Analytics, Matomo) ein, um Besucher-Informationen wie z.B. Browser, Land, oder die Dauer, wie lange ein Benutzer auf unserer Seite verweilt, zu messen. Ihre IP-Adresse wird anonymisiert übertragen, die Verbindung zu Google ist verschlüsselt.

Nur notwendige Cookies zulassen:
Wir verzichten auf den Einsatz von Analysetools. Es werden jedoch technisch notwendige Cookies, die eine reibungslose Navigation und Nutzung der Webseite ermöglichen, gesetzt (beispielsweise den Zugang zum zugangsbeschränkten Bereich erlauben).

Sie können Ihre Cookie-Einstellung jederzeit auf der Seite Datenschutzerklärung ändern. Zum Impressum.


Cookies zulassen Nur notwendige Cookies zulassen